519 related articles for article (PubMed ID: 32698494)
1. Self-Amplifying RNA Viruses as RNA Vaccines.
Lundstrom K
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698494
[TBL] [Abstract][Full Text] [Related]
2. Replicon RNA Viral Vectors as Vaccines.
Lundstrom K
Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27827980
[TBL] [Abstract][Full Text] [Related]
3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
4. Self-Replicating RNA Viruses for RNA Therapeutics.
Lundstrom K
Molecules; 2018 Dec; 23(12):. PubMed ID: 30551668
[TBL] [Abstract][Full Text] [Related]
5. Applications of self-replicating RNA.
Lundstrom K
Int Rev Cell Mol Biol; 2022; 372():97-157. PubMed ID: 36064268
[TBL] [Abstract][Full Text] [Related]
6. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
7. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
[TBL] [Abstract][Full Text] [Related]
8. Viral Vectors for COVID-19 Vaccine Development.
Lundstrom K
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669550
[TBL] [Abstract][Full Text] [Related]
9. Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer.
Lundstrom K
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696295
[TBL] [Abstract][Full Text] [Related]
10. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2017; 1581():225-242. PubMed ID: 28374252
[TBL] [Abstract][Full Text] [Related]
11. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2016; 1404():313-328. PubMed ID: 27076308
[TBL] [Abstract][Full Text] [Related]
12. Measles-derived vaccines to prevent emerging viral diseases.
Frantz PN; Teeravechyan S; Tangy F
Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
[TBL] [Abstract][Full Text] [Related]
13. Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.
Lundstrom K
Viruses; 2020 Nov; 12(11):. PubMed ID: 33218001
[TBL] [Abstract][Full Text] [Related]
14. Alphavirus-Based Antigen Preparation.
Lundstrom K
Methods Mol Biol; 2021; 2183():63-81. PubMed ID: 32959241
[TBL] [Abstract][Full Text] [Related]
15. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
16. Vaccine platform recombinant measles virus.
Mühlebach MD
Virus Genes; 2017 Oct; 53(5):733-740. PubMed ID: 28710608
[TBL] [Abstract][Full Text] [Related]
17. RNA Viruses as Tools in Gene Therapy and Vaccine Development.
Lundstrom K
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30832256
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
Aberle JH; Aberle SW; Kofler RM; Mandl CW
J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
[TBL] [Abstract][Full Text] [Related]
19. Alphavirus-based vaccines.
Lundstrom K
Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
[TBL] [Abstract][Full Text] [Related]
20. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.
Anraku I; Harvey TJ; Linedale R; Gardner J; Harrich D; Suhrbier A; Khromykh AA
J Virol; 2002 Apr; 76(8):3791-9. PubMed ID: 11907219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
